9.500GBP0.00%Mkt Cap: 31.58M $P/E: —1d ago
SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, a…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap31.58M $
Enterprise Value28.78M $
Revenue (TTM)6.70M $
Gross Profit3.67M $
Net Income (TTM)-893.02K $
Revenue/Share0.0269 USD
Last Price9.500 GBP
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees41
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)49.60
PEG—
EV/EBITDA-30.55
EV/Revenue4.29
P/S4.65
P/B3.02
EPS (TTM)0.00
EPS (Forward)0.00
52W Range
0.097541% of range23.00
52W High23.00 GBP
52W Low0.0975 GBP
Profitability
Gross Margin61.65%
Oper. Margin-46.53%
EBITDA Margin-14.05%
Profit Margin-15.01%
ROE-7.39%
ROA-5.74%
Growth
Revenue Growth37.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.58M $
CapEx (TTM)203.72K $
FCF Margin-26.90%
FCF Yield-5.71%
Net Debt-2.80M $
Net Debt/EBITDA2.98
Balance Sheet
Debt/Equity0.11
Current Ratio6.14
Quick Ratio4.96
Book Value/Sh0.0310 GBP
Cash/Share0.0120 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)29.00 GBP
Upside (mean)+205.3%
Target Range29.00 GBP – 29.00 GBP
# Analysts1
Ownership
Shares Out.259.17M
Float121.83M
Insiders41.20%
Institutions13.41%
Technical
SMA 5010.76 (-11.7%)
SMA 20010.64 (-10.7%)
Beta0.12
S&P 52W Chg18.16%
Avg Vol (30d)319.42K
Avg Vol (10d)209.65K
Technical Indicators
RSI (14)36.2
MACD-0.1830
MACD Signal0.1395
MACD Hist.-0.3225
BB Upper12.99 GBP
BB Middle11.14 GBP
BB Lower9.283 GBP
BB Width33.31%
ATR (14)0.8558 GBP
Vol Ratio (20d)0.06x